Sweetgreen (SG): 90% Down—Turnaround or Trap? 🥗📉

Split illustration of a fresh healthy salad on one side and a wilted version on the other, symbolizing the contrast between Sweetgreen’s strong brand and its struggling stock performance.

Goldman Buys, Shorts Attack—What’s Next for Sweetgreen?

Sweetgreen (SG) Stock Analysis: Why Goldman Sachs Is Buying Despite a “Sell” Rating 🥗

NYSE: SG
$5.61 | -0.21 (-3.61%)
As of Apr-09-2026 4:10 PM ET

🎯  FunStock Index™ : 6.8 / 10 🎯

Tooltip: A speculative, high-volatility setup with some contrarian appeal—but the fundamentals still look more wilted than fresh. This is not yet a clean health-food story for your portfolio.


At FUNanc1al, we appreciate a good “green” play.

Usually, however, we prefer the kind that shows up in margins, cash flow, and shareholder returns—not just in kale, arugula, and ethically sliced chicken.

Sweetgreen is one of those stocks that sounds fantastic in theory: healthy fast food, premium branding, digital ordering, automation, urban footprint, tech-enabled operations, maybe even a robotics kicker. It is basically trying to be the Tesla of lunch.

Unfortunately, the current financials look less like a superfood bowl and more like a dressing spill.

Still, the stock is down nearly 90% from its post-IPO peak, the short interest is huge, Goldman Sachs owns a meaningful stake while maintaining a Sell rating, and insiders including the CEO have bought shares. So yes, the setup is weird enough to deserve a look.

Let’s open the salad container carefully.


🕵️ Trigger #1: The Goldman Sachs Paradox

If you were looking for Wall Street absurdity, congratulations, you found it.

Goldman Sachs has maintained a Sell rating on Sweetgreen, with a target roughly around the current price area. Yet Goldman and affiliates also hold a stake above 10%, and recently bought roughly 594,553 shares for about $3.3 million.

At first glance, this looks like the kind of contradiction that makes retail investors want to throw a crouton at a Bloomberg terminal.

But the likely explanation is less scandalous and more boring:

👉 Goldman’s research view and Goldman’s market-making / client facilitation activity are not the same thing.

In plain English:

  • the analysts can dislike the stock,
  • while the trading and market-making side still buys shares to facilitate flow, hedge exposure, or manage inventory.

So no, this is not necessarily Goldman “secretly loving” Sweetgreen.

But it is still notable that such a large institutional player is deeply involved in a stock trading near the floorboards.

And it gets more interesting because Goldman is not alone.


🥬 Trigger #2: Insiders and Institutions Still Believe… Sort Of

Sweetgreen insiders have also been buying.

Most notably:

  • CEO Jonathan Neman bought roughly $1 million worth of stock in late 2025
  • Chief Concept Officer Nicolas Jammet bought shares more than once, including again in March 2026

None of these are “bet the farm” purchases relative to billionaire bravado, but they are real buys in a stock that has been badly bruised.

Institutional ownership is also very high:

  • 89.25% of shares held by institutions
  • 92.50% of float held by institutions (with Baillie Gifford owning 10.02% of shares outstanding, Vanguard Group 8.94%, and Blackrock 7.34%)

That tells us two things:

  1. Serious money is still involved
  2. If the story improves, the move could be sharp because positioning is crowded

Of course, high institutional ownership does not magically make a stock good. Sometimes it just means a lot of professionals are trapped at a fancier table.

🔍 For Sweetgreen (SG)'s Institutional Ownership breakdown, see here


🐻 Trigger #3: Shorts Are Absolutely in the Kitchen

Now for the spicy part.

Short interest sits around:

  • 24.06% of float
  • 5.72 days to cover

That is a serious bearish bet.

And unlike Nike or some other cleaner blue chips, Sweetgreen actually does have real short-squeeze potential. When short interest is this high and days-to-cover is elevated, any upside surprise—a better-than-feared quarter, a menu hit, improved traffic, a credible margin recovery—can force a painful rush for the exits.

So yes, this is a crowded trade.

But crowded does not automatically mean wrong.

Sometimes the shorts are early.
Sometimes they are right.
Sometimes they are both.


📉 Trigger #4: The Actual Business Looks… Wilted

Here is where we need to stop flirting with the chart and look at the bowl itself.

Sweetgreen’s Q4 and full-year 2025 numbers were rough. Based on the company’s results, fourth-quarter revenue fell 3.5% to $155.2 million, same-store sales dropped 11.5%, loss from operations widened to $(48.1) million, and adjusted EBITDA came in at $(13.3) million. For full-year 2025, revenue grew just 0.4% to $679.5 million, while same-store sales fell 7.9% and adjusted EBITDA slipped to $(11.0) million.

That is not a turnaround.
That is a business in active discomfort.

Even worse, management explicitly said 2025 fell short of expectations and highlighted traffic softness, weaker same-store trends, and the disruptive loyalty transition. The company also pointed to more selective consumers and pressure on restaurant-level economics.

And then there is operating cash flow; it deteriorated sharply, flipping from healthy positive territory in 2024 to negative in 2025; specifically, net cash (used in) provided by operating activities was (12.696M) in fiscal 2025 vs 43.390M in fiscal 2024. That is exactly the sort of thing that makes bulls start chewing nervously.

👉 Want the full picture? Dive into Sweetgreen (SG)'s financials here.


🤖 Trigger #5: Infinite Kitchen, Wraps, and Other Hope-Based Proteins

To Sweetgreen’s credit, management is not sitting there pretending everything is fine while quietly rearranging the avocado.

They are trying things.

The company sold Spyce to Wonder for significant consideration, while still retaining rights to use and deploy Infinite Kitchen technology through supply and licensing agreements. At the same time, management is leaning on what it calls the Sweet Growth Transformation Plan, testing wraps and trying to sharpen value perception, operational execution, and restaurant-level margins.

That is the bull case in one sentence:

👉 If automation helps throughput and labor efficiency,
👉 if menu innovation helps traffic,
👉 if same-store sales stabilize,
👉 then this thing could rerate violently from depressed levels.

The problem is that none of those “ifs” has been cleanly proven yet.

Infinite Kitchen sounds cool.
But investors cannot eat buzzwords for lunch.


💰 Valuation: Cheap… But Cheap for a Reason

Sweetgreen now trades at:

  • about 0.94x sales
  • around 1.8x book
  • nearly 90% below its IPO-era highs

On the surface, that screams “cheap growth stock.”

But we need to be careful. Since the company is not profitable and earnings-based metrics are basically unusable, the low multiple mostly tells us one thing:

👉 The market no longer believes the old story.

That can create opportunity.

It can also create a value trap.

A low price-to-sales ratio on a company with:

  • falling same-store sales,
  • worsening losses,
  • negative operating cash flow,
  • and a pressured consumer base

…is not automatically a bargain.

Sometimes it is just the menu price on disappointment.

💡💡💡 Curious about another deep oil exploration play? (Just joking)
Check our takes on UnitedHealth Group or even Oscar Health


🎯 The FUNanc1al Verdict

Sweetgreen is not a clean long.

It is not a quality compounder.

It is not a “buy and forget” stock.

What it is, however, is a high-risk contrarian setup with three things going for it:

  • heavy institutional ownership
  • insider buying
  • genuine short-squeeze potential

Against that, the bear case remains very real:

  • same-store sales are ugly
  • profitability is nowhere near solid
  • operating cash flow deteriorated
  • the core customer may be under pressure (with the firm’s primary 25-35 year-old demographic under financial stress, which lowers demand for premium, fast-casual meals)
  • management still has a lot to prove

So what should investors do?

Treat Sweetgreen like an optionality play, not a conviction cornerstone.

A starter stake? Maybe, if you understand the risk and can stomach volatility.

A large position because “healthy food has to win eventually”? That sounds like the kind of sentence people may say right before losing money in a very artisanal way.


✅ FAQ

Q: Why did Goldman buy shares while keeping a Sell rating?
Most likely because its market-making and client facilitation activity is separate from its research view.

Q: Is Sweetgreen a short-squeeze candidate?
Yes. With short interest above 24% and days-to-cover above 5, squeeze dynamics are real.

Q: Is the stock cheap?
On sales and book value, yes. On business quality, that is much less clear.

Q: What is the biggest risk?
That traffic stays weak and losses continue, turning “cheap” into “chronically cheap.”

Q: What is the biggest upside catalyst?
Improvement in same-store sales, better restaurant-level economics, and proof that Infinite Kitchen can materially help margins.


⚡ Quick Take / TL;DR

  • Goldman owns a big stake while still rating the stock Sell
  • Insiders, including the CEO, have bought shares
  • Institutional ownership is very high
  • Short interest is huge, so squeeze potential is real
  • But the fundamentals are ugly: weak sales, widening losses, negative cash flow

👉 Sweetgreen is a speculative contrarian trade, not a clean investment thesis (at least not yet).


🧠 Food for Thought: The Cross-Hub Connection

Sweetgreen is a fascinating intersection of:

  • health → people want better food
  • tech → automation and digital ordering
  • consumer behavior → premium pricing in a stressed demographic
  • finance → when a beautiful concept runs into ugly economics

The deeper lesson?

Not every mission-driven brand becomes a great stock.

Sometimes the salad is healthier than the balance sheet.


✍️ About the Author

Frédéric Marsanne is the founder of FUNanc1al — part market analyst, part storyteller, part accidental comedian. A longtime investor, entrepreneur, and venture-builder across tech, biotech, and fintech, he now blends sharp insights with a twist of humor to help readers laugh, learn, live better lives, and invest a little wiser. When not decoding insider buys or poking fun at earnings calls, he’s building Cl1Q, writing fiction, painting, or discovering new passions to FUNalize.


🧾⚠️📢 Fun(anc1al) but Serious Disclaimer: 🧾⚠️📢

This article is for educational and entertainment purposes only and does not constitute financial advice. Even if insiders are buying like they just found the cheat code. 

Sweetgreen may one day become a great turnaround story.
At the moment, though, it still looks like a salad bowl full of promise, red flags, and expensive toppings.

Stocks go down. Sometimes a lot. Sometimes for good reasons. Sometimes for no reason at all. Investing in them involves significant risk, including loss of capital. Always do your own research, mind your position sizing, know your risk tolerance, and consult a licensed financial professional if needed. 

👉 And remember: past performance is not indicative of future health… or wealth.
👉
Resist FOMO and never invest money you can’t afford to lose or mistake a charismatic CEO for a guarantee. 

We laugh, we analyze, we meme.
We’re FUNanc1al — not advisors. 😄📉📈

Invest at your own risk! 🎢📉
Love at any pace. Laugh at every turn. 😄

Be Happy. 😄😄


🧭 Looking for a Different Angle?

😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny

 


Got a thought? A tip? A tale? We’re all ears — drop it below.:

Please note, comments must be approved before they are published